文献速递腹部介入CTUSDSA

经皮经胆囊造瘘管作为唯一入路取出胆囊管、肝总管及胆总管结石

Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones.
PubMed 文献 · AJR Am J Roentgenol · 2020-09-09

该回顾性研究纳入21例急性胆囊炎合并胆总管结石或胆囊管结石嵌顿、存在胆囊切除术禁忌或内镜取石失败的患者,经皮经胆囊造瘘管行透视引导下取石。初次技术成功率76%,二次技术成功率100%,临床成功率74%,无重大并发症。

要点

  • 经皮经胆囊造瘘管可作为一种取出胆总管及胆囊管结石的入路。
  • 初次技术成功率76%,二次技术成功率100%,临床成功率74%。
  • 所有患者耐受良好,无重大并发症。

关键影像表现/征象

  • 经皮经胆囊造瘘管途径在随访 session 中行胆总管取石(17例)和胆囊管取石(9例),共完成32次取石操作。
  • 17例行球囊扩张括约肌切开术后用顺应性球囊将胆总管结石推入十二指肠。
  • 7例另用取石篮取出胆囊管结石。

诊断标准与关键数值

  • 初次技术成功率(取出所有胆总管及胆囊管结石)为76%。
  • 二次技术成功率为100%。
  • 临床成功率为74%。

临床应用与阅片要点

  • 对于存在胆囊切除术禁忌或内镜取石失败的胆总管结石或胆囊管结石嵌顿患者,可考虑经皮经胆囊造瘘管作为取石入路。
  • 操作在中等镇静下进行,所有患者耐受良好,无重大并发症。

局限性

  • 原文为回顾性研究。
  • 样本量较小(21例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE. The purpose of this article was to evaluate the feasibility and efficacy of percutaneous fluoroscopic-guided stone retrieval from the cystic duct and antegrade common bile duct (CBD) stone advancement into the duodenum exclusively through a cholecystostomy tube. MATERIALS AND METHODS. Twenty-one patients with acute cholecystitis and choledocholithiasis or an impacted cystic duct stone who underwent percutaneous cholecystostomy tube placement were retrospectively enrolled in this study. The patients had a contra-indication for cholecystectomy (17 patients because of comorbidities and one who declined surgery) or had failed endoscopic retrograde stone removal attempts (three patients). RESULTS. The 21 patients underwent subsequent percutaneous CBD (17 patients) and cystic duct (nine patients) stone removal on follow-up sessions through the percutaneous cholecystostomy track using moderate sedation. A total of 32 stone removal procedures were performed. Seventeen patients underwent balloon dilatation sphincterotomy, after which the CBD stones were pushed forward into the duodenum using a compliant balloon. Seven patients also had stone removal from the cystic duct by a stone retrieval basket. The primary technical success rate for removal of all CBD and cystic duct stones was 76%. The secondary technical success rate was 100%. The clinical success rate was 74%. All patients tolerated the procedures well without major complication. The clinical follow-up interval ranged from 2 to 2310 days (median, 30 days), with no incidence of postprocedural complications. CONCLUSION. Percutaneous transcholecystic common bile and cystic duct stone removal through an existing cholecystostomy access is a safe and effective procedure that is well tolerated.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Michell H, Johnston GP, Chopra P, et al. Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones. AJR Am J Roentgenol. 2020. PMID: 32901566. doi:10.2214/AJR.19.22469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。